MULTIPLAN CORP (MPLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MPLN - US62548M2098 - Common Stock
23.15 USD
-0.36 (-1.53%)
23.15 USD
0 (0%)
Taking everything into account, MPLN scores 2 out of 10 in our fundamental rating. MPLN was compared to 35 industry peers in the Health Care Technology industry. MPLN has a bad profitability rating. Also its financial health evaluation is rather negative. MPLN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MPLN has reported negative net income.
MPLN had a positive operating cash flow in the past year.
MPLN had negative earnings in 4 of the past 5 years.
Each year in the past 5 years MPLN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -31.95%, MPLN is in line with its industry, outperforming 50.00% of the companies in the same industry.
MPLN's Return On Equity of -1958.81% is on the low side compared to the rest of the industry. MPLN is outperformed by 81.58% of its industry peers.
MPLN has a Return On Invested Capital of 1.58%. This is in the better half of the industry: MPLN outperforms 76.32% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MPLN is below the industry average of 6.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.95% | ||
| ROE | -1958.81% | ||
| ROIC | 1.58% |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 10.63%, MPLN belongs to the top of the industry, outperforming 92.11% of the companies in the same industry.
MPLN's Operating Margin has declined in the last couple of years.
The Gross Margin of MPLN (74.27%) is better than 84.21% of its industry peers.
MPLN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% |
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MPLN is destroying value.
Compared to 1 year ago, MPLN has about the same amount of shares outstanding.
Compared to 5 years ago, MPLN has less shares outstanding
The debt/assets ratio for MPLN is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.30, we must say that MPLN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MPLN (-0.30) is comparable to the rest of the industry.
A Debt/Equity ratio of 53.67 is on the high side and indicates that MPLN has dependencies on debt financing.
MPLN's Debt to Equity ratio of 53.67 is on the low side compared to the rest of the industry. MPLN is outperformed by 81.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.3 |
ROIC/WACC0.25
WACC6.29%
2.3 Liquidity
MPLN has a Current Ratio of 0.82. This is a bad value and indicates that MPLN is not financially healthy enough and could expect problems in meeting its short term obligations.
MPLN has a worse Current ratio (0.82) than 76.32% of its industry peers.
MPLN has a Quick Ratio of 0.82. This is a bad value and indicates that MPLN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.82, MPLN is not doing good in the industry: 71.05% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The earnings per share for MPLN have decreased strongly by -1059.83% in the last year.
MPLN shows a decrease in Revenue. In the last year, the revenue decreased by -3.21%.
The Revenue has been decreasing by -1.09% on average over the past years.
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%
3.2 Future
Based on estimates for the next years, MPLN will show a very strong growth in Earnings Per Share. The EPS will grow by 36.67% on average per year.
The Revenue is expected to grow by 2.09% on average over the next years.
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MPLN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MPLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
94.74% of the companies in the same industry are more expensive than MPLN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.19 |
4.3 Compensation for Growth
MPLN's earnings are expected to grow with 36.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A
5. Dividend
5.1 Amount
MPLN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.15
-0.36 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners47.86%
Inst Owner Change24.91%
Ins Owners6%
Ins Owner Change0%
Market Cap375.03M
Revenue(TTM)930.62M
Net Income(TTM)-1.65B
Analysts77.78
Price Target13.94 (-39.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.46%
Min EPS beat(2)-73.58%
Max EPS beat(2)14.65%
EPS beat(4)2
Avg EPS beat(4)-370.31%
Min EPS beat(4)-1467.36%
Max EPS beat(4)45.02%
EPS beat(8)5
Avg EPS beat(8)-168.93%
EPS beat(12)6
Avg EPS beat(12)-282.74%
EPS beat(16)9
Avg EPS beat(16)-181.58%
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.88%
Revenue beat(4)0
Avg Revenue beat(4)-4.72%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)-2.88%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)3
Avg Revenue beat(12)-3.01%
Revenue beat(16)6
Avg Revenue beat(16)-1.99%
PT rev (1m)26.15%
PT rev (3m)24.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.98%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | 3.48 | ||
| P/B | 4.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.19 |
EPS(TTM)-69.59
EYN/A
EPS(NY)-9.03
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)6.64
OCFY28.7%
SpS57.45
BVpS5.19
TBVpS-280.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.95% | ||
| ROE | -1958.81% | ||
| ROCE | 2% | ||
| ROIC | 1.58% | ||
| ROICexc | 1.59% | ||
| ROICexgc | 26.88% | ||
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% | ||
| FCFM | N/A |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexgc growth 3Y-40.96%
ROICexgc growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score3
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.49 | ||
| Cap/Depr | 27.34% | ||
| Cap/Sales | 12.69% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 20.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | -0.3 |
F-Score3
WACC6.29%
ROIC/WACC0.25
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.76%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year144.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-116.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.33%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%
MULTIPLAN CORP / MPLN FAQ
Can you provide the ChartMill fundamental rating for MULTIPLAN CORP?
ChartMill assigns a fundamental rating of 2 / 10 to MPLN.
What is the valuation status for MPLN stock?
ChartMill assigns a valuation rating of 2 / 10 to MULTIPLAN CORP (MPLN). This can be considered as Overvalued.
What is the profitability of MPLN stock?
MULTIPLAN CORP (MPLN) has a profitability rating of 3 / 10.
What is the financial health of MULTIPLAN CORP (MPLN) stock?
The financial health rating of MULTIPLAN CORP (MPLN) is 1 / 10.